Use of mesenchymal stem cell therapy in COVID-19 related strokes

Use of mesenchymal stem cell therapy in COVID-19 related strokes

Coronavirus disease 2019 (COVID-19) has affected a broad demographics, eliciting a more significant effect on specific groups such as males, African Americans, and Hispanic minorities. Treatment of COVID-19 often requires antiviral drugs or monoclonal antibodies. However, immunotherapies such as mes...

Full description

Bibliographic Details
Main Authors: Mahika Rawat, Chiao Ng, Emaad Khan, Rayyan A Shah, Suha Ashfaq, Ghaith A Bahader, Zahoor A Shah
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2023-01-01
Series:Neural Regeneration Research
Subjects:
covid-19; cytokines; immunotherapy; interleukin-7; mesenchymal stem cells; neuroinflammation; sex differences; stroke
Online Access:http://www.nrronline.org/article.asp?issn=1673-5374;year=2023;volume=18;issue=9;spage=1881;epage=1883;aulast=Rawat

Internet

http://www.nrronline.org/article.asp?issn=1673-5374;year=2023;volume=18;issue=9;spage=1881;epage=1883;aulast=Rawat

Similar Items